SPYRE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.56 USD | +3.36% |
|
+3.55% | +55.95% |
| 04-19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
| 04-19 | Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares | MT |
Chart calendar Spyre Therapeutics, Inc.
35864985f8aa2a733468d49b049c.W8OVNQ4iucsufsTiJaHimoN8kfVFiL62g6QyNtbX5ko.PprvATpUi_JYNoCyZNSn88RN9rQj0v_w5OVcXo-DqgYQs8dhaUjmp19JjQ~cac35fc47da3c3d3056b0c8b8ce626ea
Upcoming events on Spyre Therapeutics, Inc.
Past events on Spyre Therapeutics, Inc.
| 05/03/2024 19:10 | TD Cowen Health Care Conference |
| 29/02/2024 21:05 | Q4 2023 Earnings Release |
| 22/02/2024 | ECCO Congress - SPY002 |
| 22/02/2024 | ECCO Congress - SPY001 |
| 22/02/2024 | ECCO Congress - Novel Extended Half-Life Monoclonal Antibody Drug |
| 20/11/2023 | Special Meeting |
| 20/11/2023 | Extraordinary Shareholders Meeting |
| 16/11/2023 13:00 | Jefferies London Healthcare Conference |
| 14/11/2023 20:35 | Stifel Healthcare Conference |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 07/11/2023 14:10 | Guggenheim Securities Inflammation & Immunology Conference |
| 20/09/2023 16:00 | Stifel Immunology & Inflammation Virtual Summit |
| 11/08/2023 12:00 | Q2 2023 Earnings Release |
| 22/06/2023 14:00 | Acquisition of Spyre Therapeutics Inc by Aeglea BioTherapeutics, Inc Call |
| 06/06/2023 15:00 | Annual General Meeting |
| 11/05/2023 12:01 | Q1 2023 Earnings Release |
| 16/03/2023 14:45 | ACMG Clinical Genetics Meeting |
| 02/03/2023 12:01 | Q4 2022 Earnings Release |
| 08/01/2023 | JP Morgan Healthcare Conference |
| 28/11/2022 | Piper Sandler Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,30 - | 0,00 0,00 - | 18,7 17,4 7.72% | 2,33 2,23 4.35% | 0,89 1,08 -18.22% | 6,82 |
|
EBITDA Million USD | Released Forecast Spread | -79,9 -83,0 3.72% | -80,5 -89,0 9.57% | 0,00 0,00 - | 0,00 0,00 - | -242 -224 -8.03% | -132 |
|
EBIT Million USD | Released Forecast Spread | -80,3 -80,8 0.62% | -81,5 -80,6 -1.05% | -65,6 -66,0 0.55% | -84,8 -83,9 -1.05% | -242 -224 -8.21% | -157 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -78,3 -78,8 0.66% | -80,9 -81,1 0.23% | -65,7 -66,1 0.7% | -84,0 -84,0 0.08% | -339 -304 -11.34% | -140 |
|
Net income Million USD | Released Forecast Spread | -78,3 -78,8 0.74% | -80,9 -80,0 -1.1% | -65,8 -66,1 0.53% | -83,8 -83,8 0% | -339 -302 -12.01% | -169 |
|
EPS USD | Released Forecast Spread | -61,3 -62,0 1.23% | -38,0 -39,0 2.56% | -25,0 -25,5 1.8% | -24,8 -25,4 2.7% | -49,1 -11,9 -314.27% | -3,52 |
| Announcement Date | 24/02/20 | 18/03/21 | 08/03/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,64 1,76 107.07% | 1,36 0,73 87.86% | 0,63 0,71 -11.91% | 0,17 0,21 -16.48% | 0,17 0,06 189.66% | 0,20 0,08 135.71% | 0,69 0,00 - | 0,00 0,00 - | 0,00 0,22 - | 0,00 | 3,33 | 0,00 | 3,50 | |
|
EBIT Million USD | Released Forecast Spread | -20,4 -21,0 2.52% | -24,4 -23,0 -6.27% | -22,4 -23,9 6.17% | -18,8 -21,0 10.64% | -19,2 -18,3 -4.78% | -18,8 -17,8 -5.42% | -159 -14,2 -1021.45% | -32,9 -21,0 -56.89% | -45,9 -29,2 -57.46% | -39,1 | -35,9 | -41,6 | -40,0 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,4 -21,0 2.55% | -24,4 -23,0 -6.3% | -22,3 -23,9 6.55% | -18,4 -20,9 11.69% | -18,8 -18,8 0.21% | -18,5 -16,6 -10.97% | -217 -14,2 -1434.09% | -40,1 -13,3 -202.67% | -63,2 -28,6 -120.91% | -36,6 | -32,4 | -39,3 | -37,0 | |
|
Net income Million USD | Released Forecast Spread | -20,4 -21,0 2.44% | -24,4 -23,0 -6.3% | -22,3 -23,9 6.51% | -18,2 -20,9 12.69% | -18,8 -18,8 0.01% | -18,4 -16,6 -10.75% | -217 -14,2 -1434.14% | -40,1 -13,3 -202.69% | -63,2 -26,8 -135.91% | -42,2 | -39,0 | -44,9 | -43,3 | |
|
EPS USD | Released Forecast Spread | -7,75 -7,63 -1.51% | -9,25 -8,59 -7.69% | -6,75 -7,75 12.9% | -4,75 -5,88 19.15% | -4,50 -5,06 11.11% | -5,00 -4,38 -14.29% | -56,8 -3,50 -1521.43% | -9,34 -0,85 -1005.33% | -4,05 -0,78 -416.39% | -1,17 | -0,89 | -0,96 | -0,90 | -0,40 |
| Announcement Date | 08/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 02/03/23 | 11/05/23 | 11/08/23 | 09/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Spyre Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYRE Stock
- Calendar Spyre Therapeutics, Inc.
